AXT Inc. priced a public offering of 8,560,311 shares of common stock at $64.25 per share, generating $550 million in gross proceeds before underwriting discounts and commissions. The offering includes an overallotment option for up to 1,284,046 additional shares, which could raise total gross proceeds to $632.5 million if fully exercised.
The company will use the net proceeds primarily to support its Beijing Tongmei Xtal Technology Co., Ltd., a subsidiary that manufactures indium phosphide (InP) substrates, and to fund research and development, working capital, and general corporate purposes. The expansion is aimed at meeting growing demand for InP in 5G infrastructure, data‑center connectivity, and AI applications.
AXT has faced declining revenue growth and a net loss in fiscal 2025, with a price‑to‑sales ratio of 39.2, indicating a potentially overvalued valuation. Insider selling of $43.3 million in the last three months adds a layer of concern. The company’s recent export‑permit challenges—delays in U.S. permits for InP exports—have pressured revenue, making the capital raise a strategic move to diversify its customer base and reduce reliance on specific regional permits.
Management has emphasized the need to double InP capacity to capture the accelerating demand for high‑performance substrates, reflecting confidence in the long‑term growth of AI infrastructure and 5G deployments. Analysts note that the offering’s dilution concerns are a short‑term headwind, but the company’s strong segment mix and strategic focus on InP position it well for future market expansion.
Market reaction to the pricing was tempered by valuation concerns, with investors weighing dilution against the company’s robust growth prospects. The company’s 52‑week high of $83.25 and its recent year‑to‑date gains indicate continued investor optimism about the long‑term upside of InP substrates.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.